BNCM: DELEX PHARMA Bolsters Market Reach Through 6 Major Conventions in November 2024

Delex Pharma International, Inc. (Delex Pharma) strengthened its market presence in 2024 by complementing its digital initiatives, such as the ICU Forum, with participation in six major on-ground conventions, the majority of which took place in November 2024. Additionally, we have conducted hybrid webinars and events with forty-four (44) partner medical societies and hospital departments. These events target key healthcare professionals across multiple specialties, enhancing brand visibility and engagement.